2016 International Congress Archives - Page 132 of 207

New therapeutic algorithm for abnormal posture in Parkinson’s disease and related disorders

Y. Mukai, Y. Furusawa, Y. Aoshima, H. Todo, Y. Hama, C. Matsumoto, N. Wakasugi, Y. Mizuno, T. Kawazoe, Y. Saitoh, T. Sakamoto, M. Murata (Tokyo, Japan)
Next-generation profiling to identify the molecular etiology of Parkinson’s disease dementia

E.D. Driver-Dunckley, J. Corneveaux, D.B. Matt, L. Cuyugan, W. Liang, M. Huentelman, T.G. Beach, C.H. Adler, A. Henderson-Smith, T. Dunckley (Scottsdale, AZ, USA)
Nighttime sleep problems in patients with Parkinson’s disease: Risk factors and longitudinal associations

K. Zhu, J.J. van Hilten, J. Marinus (Leiden, Netherlands)
Nigrostriatal degeneration and serum BDNF levels in patients with “de novo” untreated Parkinson’s disease

G. Marti, N. Saez, M. Corominas, G. Cuberas, C. Lorenzo, O. De Fabregues, J. Alvarez-Sabin, M. Casas, J. Hernandez (Barcelona, Spain)
Nilotinib improves motor skills, cognition and autonomic function in open-label phase I clinical trial in Parkinson’s disease with dementia and Lewy body dementia

F. Pagan, E. Valadez, Y. Torres-Yaghi, A. Keys, R. Falconer, S. Rogers, B. Wilmarth, M. Hebron, C. Moussa (Washington, DC, USA)
Nilotinib significantly alters CSF biomarkers and increases endogenous dopamine in open-label phase I clinical trial in Parkinson’s disease with dementia and Lewy body dementia

C. Moussa, E. Valadez, Y. Torres-Yaghi, A. Keys, R. Falconer, S. Rogers, B. Wilmarth, M. Hebron, F. Pagan (Washington, DC, USA)
Ninjurin 1 gene D110a single nucleotide polymorphism as a genetic marker for nerve damage leprosy patients from South India

A. Sundaramoorthy, S. Keshavarao, A. Valsala Gopalakrishnan (Coimbatore, India)
No RAB39B gene mutations in Chinese familial Parkinson’s disease

J.F. Guo, J.F. Kang, X.X. Yan, B.S. Tang (Changsha, People's Republic of China)
Non motor symptoms burden and motor staging of Parkinson’s disease: Evidence for dichotomy and non-motor dominant subtypes from analysis of 249 cases

K. Ray Chaudhuri, A. Sauerbier, T. Thavayogarajah, A. Rizos, L. Perkins, C. Rodriguez Blazquez, P. Martinez-Martin, On behalf of EUROPAR, the MDS Non-Motor PD Study Group, The NILS Group (London, United Kingdom)
Non motor symptoms of Parkinson’s disease: Prevalence and impact on quality of life

M. Chraa, K. Choulli, N. Kissani (Marrakech, Morocco)